TTK HEALTHCARE
Back to Cashflow Statement
|
TTK HEALTHCARE Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-18 Cr | ₹-22 Cr | ₹-12 Cr | ₹-10 Cr | ₹-17 Cr |
What is the latest Cash Flow from Financing Activities ratio of TTK HEALTHCARE ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹-18 Cr |
Mar2024 | ₹-22 Cr |
Mar2023 | ₹-12 Cr |
Mar2022 | ₹-10 Cr |
Mar2021 | ₹-17 Cr |
How is Cash Flow from Financing Activities of TTK HEALTHCARE Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-18 Cr | Negative | |
Mar2024 | ₹-22 Cr | Negative | |
Mar2023 | ₹-12 Cr | Negative | |
Mar2022 | ₹-10 Cr | Negative | |
Mar2021 | ₹-17 Cr | - |
Compare Cash Flow from Financing Activities of peers of TTK HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TTK HEALTHCARE | ₹1,899.7 Cr | -0.1% | 7% | -6.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,091.0 Cr | 2.3% | 3.2% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,302.0 Cr | -0.2% | 4.5% | 49.6% | Stock Analytics | |
CIPLA | ₹119,038.0 Cr | -0.2% | -2% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹117,170.0 Cr | 3.7% | 6.5% | 16.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,061.0 Cr | -0% | -4.6% | -6.2% | Stock Analytics |
TTK HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TTK HEALTHCARE | -0.1% |
7% |
-6.3% |
SENSEX | -1.1% |
1% |
3.4% |
You may also like the below Video Courses